semaglutide compounding pharmacy australia The hunt for the Australian 'cowboy' pharmacist behind a replica Ozempic and Mounjaro scam Australia to ban knock-offs of

Start Low, Go Slow Dose increased gradually over several weeks to minimize side effects

This explosion in demand led to a shortage in GLP-1 supply, starting with semaglutide, the key ingredient in Wegovy, in March 2022

Cardiovascular benefits associated with some GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) observed in clinical trials are likely to diminish after discontinuation, though the exact persistence of these benefits remains uncertain

Sawyer SM, Whitelaw M, LeGrange D, Yeo M, Hughes D

Last process review: June 10, 2026

503A pharmacies compound individual prescriptions and are regulated by state boards